In malignant gliomas, GLS-2 is commonly downregulated, but GLS-1 is expressed [4,56,57], being pivotal in glutaminolysis, which in turn is crucial for GBM cell survival and tumor growth [58]. The gene discussed is GLS; the disease is malignant glioma.